Across TCGA pan-cancer cohorts, PILRB RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of PILRB’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where PILRB RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PILRB is over-expressed in tumor.
COAD, HNSC, and KIRC are the cancer types where PILRB tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PILRB RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.